These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 11606925

  • 1. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E, Burgdorf WH, Wollenberg A.
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC, Fleisher AB.
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
    Bos JD.
    Eur J Dermatol; 2003 Nov; 13(5):455-61. PubMed ID: 14693489
    [Abstract] [Full Text] [Related]

  • 10. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135
    [Abstract] [Full Text] [Related]

  • 11. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec 14; 13(74):209-12. PubMed ID: 15599989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT, Thaçi D, Luger T.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep 14; 146(1):22-9. PubMed ID: 19631446
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M, Steinhoff M, Schneider D, Luger TA.
    Exp Dermatol; 2004 Dec 14; 13(12):721-30. PubMed ID: 15560755
    [Abstract] [Full Text] [Related]

  • 15. Topical tacrolimus.
    Frankel SJ, Kerdel FA.
    Skin Therapy Lett; 2001 Dec 14; 6(4):1-2, 5. PubMed ID: 11176043
    [Abstract] [Full Text] [Related]

  • 16. Calcineurin inhibitors and rapamycin: cancer protection or promotion?
    Weischer M, Röcken M, Berneburg M.
    Exp Dermatol; 2007 May 14; 16(5):385-93. PubMed ID: 17437481
    [Abstract] [Full Text] [Related]

  • 17. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug 14; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 18. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
    Langley RG, Luger TA, Cork MJ, Schneider D, Paul C.
    Dermatology; 2007 Aug 14; 215 Suppl 1():27-44. PubMed ID: 18174691
    [Abstract] [Full Text] [Related]

  • 19. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR.
    Semin Cutan Med Surg; 2001 Dec 14; 20(4):268-74. PubMed ID: 11770914
    [Abstract] [Full Text] [Related]

  • 20. [Topical tacrolimus in dermatology: what can one expect?].
    Lacour JP.
    Ann Dermatol Venereol; 2001 Dec 14; 128(12):1291-4. PubMed ID: 11908129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.